Acorah Software Products - Accounts Production 19.2.350 true true 31 May 2025 1 June 2024 false true No description of principal activity 1 June 2025 31 May 2026 31 May 2026 NI687851 Mr Martin McNally iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure NI687851 2025-05-31 NI687851 2026-05-31 NI687851 2025-06-01 2026-05-31 NI687851 frs-bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 NI687851 frs-bus:FilletedAccounts 2025-06-01 2026-05-31 NI687851 frs-bus:Micro-entities 2025-06-01 2026-05-31 NI687851 frs-bus:EntityHasNeverTraded 2025-06-01 2026-05-31 NI687851 frs-bus:AuditExempt-NoAccountantsReport 2025-06-01 2026-05-31 NI687851 frs-bus:Director1 2025-06-01 2026-05-31 NI687851 2024-05-31 NI687851 2025-05-31 NI687851 2024-06-01 2025-05-31
Registered number: NI687851
Pharmscription Ltd
Dormant Financial Statements
For The Year Ended 31 May 2026
Flynn & Company Accountants Limited
Balance Sheet
Registered number: NI687851
2026 2025
£ £
Current assets 100 100
NET CURRENT ASSETS 100 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100 100
NET ASSETS 100 100
CAPITAL AND RESERVES 100 100

Notes

1. General Information
Pharmscription Ltd is a private company, limited by shares, incorporated in Northern Ireland, registered number NI687851 . The registered office is 28 Carleton Street, Portadown, Craigavon, BT62 3EP.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
- -
For the year ending 31 May 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Martin McNally
Director
09/06/2026